Loading...
Hill-Rom Holdings, Inc.
HRC•NYSE
Healthcare
Medical - Instruments & Supplies
$155.96
$0.05(0.03%)

The company's financials show resilient growth, with revenue advancing from $741.00M in Q4 2020 to $797.90M in Q3 2021. Gross profit remained healthy with margins at 54% in Q3 2021 compared to 8% in Q4 2020. Operating income hit $121.40M last quarter, sustaining a consistent 15% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $127.60M. Net income rose to $53.40M, while earnings per share reached $0.81. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan